20 AUG, 2020 Since Tuesday evening, some 5,000 women have responded to Emma Children Hospital’s call to donate breast milk. “Our researchers are very enthusiastic about the overwhelming response,” according to a spokesperson of the Emma...
PRESS RELEASE REPROCELL and VIROCLINICS-DDL Launch New Collaboration in Clinical Research Rotterdam, The Netherlands, VIROCLINICS-DDL is pleased to announce the signing of a new collaboration agreement with REPROCELL. REPROCELL will provide...
Rotterdam, November 3rd The French ministry of research and innovation approves Viroclinics Biosciences as an intermediate vendor, according to Art. 244 quarter B of the French Fiscal Code. The French Tax Credit Incentive (Crédit d’Impôt Recherche or CIR) is a tax...
Viroclinics Biosciences serves as a virology contract research organization in the bio pharmaceutical community with preclinical, clinical diagnostic, assay development and clinical trial logistics services. Especially with extensive experience in clinical and...
Selecting vaccine strains that match circulating influenza viruses antigenically remains an annual challenge. Vaccine mismatch [e.g., for recent A(H3N2) viruses] has contributed to reduced vaccine effectiveness. Reduced vaccine effectiveness not only may affect public...
